All Categories
Alzchem supports many scientific studies to generate new insights into the effects and applications of creatine, particularly in the health sector.
We wish you and your family a Merry Christmas and a peaceful festive season.
On Thursday, 28 November 2024, Alzchem honoured this year's anniversary celebrants and at the same time bid farewell to 33 employees as they retire from active professional life.
Munich's team in the European League of American Football (ELF), is starting its pre-season preparations with German creatine.
Alzchem Group AG has been informed by its shareholders, LIVIA Corporate Development SE und HDI Vier CE GmbH, that the announced private placement of 250,000 shares (representing approximately 2.5% of the share capital) through an accelerated bookbuilding process with institutional investors has been successfully completed.
LIVIA Corporate Development SE and HDI Vier CE GmbH have informed Alzchem Group AG (ISIN DE000A2YNT30, WKN A2YNT3, Prime Standard) today that they intend to sell a total of up to 250.000 shares of Alzchem Group AG in a private placement.
Alzchem Group AG, a globally active specialty chemicals company, is setting the course for continuous and sustainably successful development in Management as well. At its meeting today, the Supervisory Board approved the appointment of Martina Spitzer as a new member of the Management Board for a term of three years from January 1, 2025 to December 31, 2027.